Payment Commission Data Act of 2019
Latest action · Oct 29, 2019 Received in the Senate and Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 14, 2019
- Passed HouseOct 28, 2019
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Cosponsors 29
Members who signed on, in the order they did. Signatures ran from Mar 14, 2019 to May 20, 2019; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MT | Greg Gianforte | Original | Mar 14, 2019 |
| D-CA | Jimmy Panetta | Original | Mar 14, 2019 |
| D-VT | Peter Welch | Original | Mar 14, 2019 |
| D-AZ | Tom O'Halleran | Original | Mar 14, 2019 |
| R-SC | Tom Rice | Original | Mar 14, 2019 |
| D-CA | Anna G. Eshoo | Mar 27, 2019 | |
| D-IL | Bobby L. Rush | Mar 27, 2019 | |
| D-MI | Debbie Dingell | Mar 27, 2019 | |
| D-CA | Doris O. Matsui | Mar 27, 2019 | |
| D-NJ | Frank Pallone, Jr. | Mar 27, 2019 | |
| R-FL | Gus M. Bilirakis | Mar 27, 2019 | |
| D-MA | Joseph P. Kennedy III | Mar 27, 2019 | |
| D-CA | Raul Ruiz | Mar 27, 2019 | |
| D-NJ | Jefferson Van Drew | Mar 28, 2019 | |
| R-OR | Greg Walden | Apr 8, 2019 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 14, 2019Markup Apr 3, 2019Reported Oct 28, 2019 |
| Health Subcommittee | Referred Mar 15, 2019Markup Mar 27, 2019Reported Mar 27, 2019 | |
| House | Ways and Means Committee | Referred Mar 14, 2019Discharged Oct 28, 2019 |
| Health Subcommittee | Referred Mar 14, 2019 | |
| Senate | Finance Committee | Referred Oct 29, 2019 |
Actions 17
Everything that happened, newest first.
- Oct 29, 2019Received in the Senate and Read twice and referred to the Committee on Finance.
- Oct 28, 2019Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
- Oct 28, 2019Committee on Ways and Means discharged.
- Oct 28, 2019Placed on the Union Calendar, Calendar No. 205.
- Oct 28, 2019Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H8519, H8526, H8527Text printed H8526 | Earl L. "Buddy" Carter R-GA, Greg Gianforte R-MT, Janice D. Schakowsky D-IL, Michael C. Burgess R-TX | Oct 28, 2019 |
| House | Debate and remarks H3800 | Ann Wagner R-MO | May 15, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Apr 30, 2019H.R. 1781, Payment Commission Data Act of 2019As ordered reported by the House Committee on Energy and Commerce on April 3, 2019
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 46, March 14, 2019, page H2747.
Related bills 6
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 19 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
| S 801 | A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. | Related bill | Mar 14, 2019 |
| HR 1264 | Payment Commission Data Act of 2019 | Identical bill | Feb 15, 2019 |
| S 2543 | Prescription Drug Pricing Reduction Act of 2019 | Related bill | Sep 25, 2019 |
| S 3129 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
- Short Title(s) as Introduced
- Payment Commission Data Act of 2019
- Short Title(s) as Reported to House
- Payment Commission Data Act of 2019
- Short Title(s) as Passed House
- Payment Commission Data Act of 2019
- Short Titles from RFS (Referred to Senate) bill text
- Payment Commission Data Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Oct 29, 2019Referred in Senate
- Oct 28, 2019Reported in House
- Oct 28, 2019Engrossed in House
- Mar 14, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
